Excipient Americas vs Gene Therapy Launchpoint Summit: Which Should You Exhibit At?

Choosing between Excipient Americas and Gene Therapy Launchpoint Summit is a decision that can define your trade show year. Both events serve the pharmaceuticals industry, but they attract different audiences, offer different opportunities, and demand different investments. Here is an honest, data-driven comparison.

Excipient Americas: The Profile

Excipient Americas takes place in Bogota, Colombia at Corferias Bogota, scheduled for 21 - 23 Jul. 2026. The event attracts approximately 1,000+ attendees and 200+ exhibitors.

Booth pricing: $5,000 - $25,000.

International pharmaceuticals trade fair bringing together exhibitors from around the world

Gene Therapy Launchpoint Summit: The Profile

Gene Therapy Launchpoint Summit takes place in Montreal, Canada at Palais des congres de Montreal, scheduled for 20 - 22 Sep. 2026. The event attracts approximately 20,000+ attendees and 1,000+ exhibitors.

Booth pricing: $3,000 - $15,000.

professional visitors only

Head-to-Head: What the Numbers Say

General business exhibitions require a different approach than specialized industry shows. Your booth competes for attention across sectors, which means your value proposition must be instantly clear to someone who may have no prior knowledge of your industry.

When evaluating Excipient Americas against Gene Therapy Launchpoint Summit, the raw numbers only tell part of the story. Attendee quality, geographic reach, and the caliber of speakers and programming all influence the true value of each event.

Cost Comparison

Direct booth costs are just the entry fee. The total cost of exhibiting includes design, shipping, team travel, accommodations, and marketing. Exhibiting in Bogota versus Montreal may involve significantly different travel and lodging expenses, which can swing the total investment by thousands of dollars.

Calculate cost per qualified lead for each event. The show with the lower booth rental is not always the better investment. A more expensive show that delivers higher-quality leads may generate a better return per dollar spent.

"Do not ask which show costs less. Ask which show makes you more."

-- Center for Exhibition Industry Research

The Verdict

Both Excipient Americas and Gene Therapy Launchpoint Summit serve the pharmaceuticals community, but they serve different segments of it. The right choice depends on three factors: where your target customers are concentrated, what your budget can support, and which event aligns with your strategic priorities for the year.

Gene Therapy Launchpoint Summit offers the larger audience, which may favor companies focused on brand exposure and volume lead generation. Excipient Americas may deliver a more concentrated, specialized audience that yields higher-quality connections.

Companies with sufficient budget should consider exhibiting at both to maximize market coverage. If forced to choose one, start with the event where your existing customers are already present — expanding within a warm network is always more efficient than breaking into a cold one.

Use our ROI Calculator to model both scenarios and browse our complete show directory to explore alternatives.